Comparative Covalent Protein Binding of 2,5-Hexanedione and 3-Acetyl-2,5-Hexanedione in the Rat

REFERENCES

• Abou-Donia, M. B., 1978. Role of acid phosphatase in delayed neurotoxicity induced by leptophos in hens, Biochem. Pharmacol. 27 (1978), pp. 2055–2058.
   PubMed Web of Science ®Google Scholar
• Alexander, R. S., and Butler, A. R., 1976. Electrophilic substitution in pyrroles. Part 1. Reaction with 4-dimethylaminobenzaldehyde (Ehrlich's reagent) in acid solution, J. Chem. Soc. Perkin Trans. II (1976), pp. 696–701.
   Google Scholar
• Amarnath, V., Valentine, W. M., Amarnath, K., Eng, M. A., and Graham, D. G., 1994. The mechanism of nucleophilic substitution of alkylpyrroles in the presence of oxygen, Chem. Res. Toxicol. 7 (1994), pp. 56–61.
   PubMed Web of Science ®Google Scholar
• Anthony, D. C., Boekelheide, K., Anderson, C. W., and Graham, D. G., 1983. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. II. Dimethyl substitution accelerates pyrrole formation and protein crosslinking, Toxicol. Appl. Pharmacol. 71 (1983), pp. 372–382.
   PubMed Web of Science ®Google Scholar
• Boya, M., Marquet, J., Moreno-Mañas, M., and Prior, M., 1979. Metal complexes in organic synthesis. III. Preparation of 3-alkylpentane-2,4-diones by alkylation of nickel bis-pentane-2,4-dionato with alkyl halides, Anal. Quim. 75 (1979), pp. 920–926.
   Google Scholar
• Chiu, F.-C., and Norton, W. T., 1982. Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament by gel filtration: Dye-binding characteristics and amino acid compositions, J. Neurochem. 39 (1982), pp. 1252–1260.
   PubMed Web of Science ®Google Scholar
• DeCaprio, A. P., 1986. Mechanisms of in vitro pyrrole adduct autoxidation in 2,5-hexanedione-treated protein, Mol. Pharmacol. 30 (1986), pp. 452–458.
   PubMed Web of Science ®Google Scholar
• DeCaprio, A. P., 2000. "n-Hexane, metabolites, and derivatives". In: Spencer, P. S., Schaumburg, H. H., and Ludolph, A. C., eds. Experimental and Clinical Neurotoxicology. New York: Oxford University Press; 2000. pp. 633–648.
   Google Scholar
• DeCaprio, A. P., Briggs, R. G., Jackowski, S. J., and Kim, J. C. S., 1988. Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat, Toxicol. Appl. Pharmacol. 92 (1988), pp. 75–85, .
   PubMed Web of Science ®Google Scholar
• DeCaprio, A. P., and Fowke, J. H., 1992. Limited and selective adduction of carboxyl-terminal lysines in the high molecular weight neurofilament proteins by 2,5-hexanedione in vitro, Brain Res. 586 (1992), pp. 219–228.
   PubMed Web of Science ®Google Scholar
• DeCaprio, A. P., Jackowski, S. J., and Regan, K. A., 1987. Mechanism of formation and quantitation of imines, pyrroles, and stable nonpyrrole adducts in 2,5-hexanedione-treated protein, Mol. Pharmacol. 32 (1987), pp. 542–548.
   PubMed Web of Science ®Google Scholar
• DeCaprio, A. P., Kinney, E. A., and Fowke, J. H., 1997. Regioselective binding of 2,5-hexanedione to high-molecular-weight rat neurofilament proteins in vitro, Toxicol. Appl. Pharmacol. 145 (1997), pp. 211–217.
   PubMed Web of Science ®Google Scholar
• DeCaprio, A. P., and O'Neill, E. A., 1985. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure, Toxicol. Appl. Pharmacol. 78 (1985), pp. 235–247.
   PubMed Web of Science ®Google Scholar
• DeCaprio, A. P., Olajos, E. J., and Weber, P., 1982. Covalent binding of a neurotoxic n-hexane metabolite: Conversion of primary amines to substituted pyrrole derivatives by 2,5-hexanedione, Toxicol. Appl. Pharmacol. 65 (1982), pp. 440–450.
   PubMed Web of Science ®Google Scholar
• Derelanko, M. J., 1987. Determination of erythrocyte life span in F-344, Wistar, and Sprague-Dawley rats using a modification of the [3H]diisopropylfluorophosphate ([3H]DFP) method, Toxicol. Sci. 9 (1987), pp. 271–276.
   Google Scholar
• deSousa, B. N, and Horrocks, L. P., 1979. Development of rat spinal cord. I. Weight and length with a method for rapid removal, Dev. Neurosci. 2 (1979), pp. 115–121.
   Web of Science ®Google Scholar
• Fedtke, N., and Bolt, H. M., 1987. 4,5-Dihydroxy-2-hexanone: A new metabolite of n-hexane and of 2,5-hexanedione in rat urine, Biomed. Environ. Mass Spectrom. 14 (1987), pp. 563–572.
   PubMedGoogle Scholar
• Fletcher, H., 1966. 1,3,4,7-Substituted isoindoles and isoindolenines, Tetrahedron 22 (1966), pp. 2481–2486.
   Web of Science ®Google Scholar
• Gardini, G. P., 1973. The oxidation of monocyclic pyrroles, Adv. Heterocyclic Chem. 15 (1973), pp. 67–98.
   Google Scholar
• Genter St.Clair, M. B., Amarnath, V., Moody, M. A., Anthony, D. C., Anderson, C. W., and Graham, D. G., 1988. Pyrrole oxidation and protein cross-linking as necessary steps in the development of γ-diketone neuropathy, Chem. Res. Toxicol. 1 (1988), pp. 179–185.
   PubMed Web of Science ®Google Scholar
• Genter, M. B., Szakál-Quin, G., Anderson, W., Anthony, D. C., and Graham, D. G., 1986. Evidence that pyrrole formation is a pathogenetic step in γ-diketone neuropathy, Toxicol. Appl. Pharmacol. 87 (1986), pp. 351–362.
   Web of Science ®Google Scholar
• Graham, D. G., Anthony, D. C., Boekelheide, K., Maschmann, N. A., Richards, R. G., Wolfram, J. W., and Shaw, B. R., 1982. Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking, Toxicol. Appl. Pharmacol. 64 (1982), pp. 415–422.
   PubMed Web of Science ®Google Scholar
• Graham, D. G., Genter St.Clair, M. B., Amarnath, V., and Anthony, D. C., 1991. Molecular mechanisms of γ-diketone neuropathy, Adv. Exp. Med. Biol. 283 (1991), pp. 427–431.
   PubMedGoogle Scholar
• Helfand, B. T., Chang, L., and Goldman, R. D., 2003. The dynamic and motile properties of intermediate filaments, Ann. Rev. Cell Dev. Biol. 19 (2003), pp. 445–467.
   PubMed Web of Science ®Google Scholar
• Krasavage, W. J., O'Donoghue, J. L., DiVincenzo, G. D., and Terhaar, C. J., 1980. The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites, Toxicol. Appl. Pharmacol. 52 (1980), pp. 433–441.
   PubMed Web of Science ®Google Scholar
• Lehning, E. J., Jortner, B. S., Fox, J. H., Arezzo, J. C., Kitano, T.-A., and LoPachin, R. M., 2000. γ-Diketone peripheral neuropathy I. Quantitative morphometric analyses of axonal atrophy and swelling, Toxicol. Appl. Pharmacol. 165 (2000), pp. 127–140.
   PubMed Web of Science ®Google Scholar
• LoPachin, R. M., and DeCaprio, A. P., 2004. γ-Diketone neuropathy: Axon atrophy and the role of cytoskeletal protein adduction, Toxicol. Appl. Pharmacol. 199 (2004), pp. 20–34.
   PubMed Web of Science ®Google Scholar
• LoPachin, R. M., and DeCaprio, A. P., 2005. Protein adduct formation as a molecular mechanism in neurotoxicity, Toxicol. Sci. 86 (2005), pp. 214–225.
   PubMed Web of Science ®Google Scholar
• LoPachin, R. M., He, D., and Reid, M. L., 2005. 2,5-Hexanedione-induced changes in the neurofilament subunit pools of rat peripheral nerve, NeuroToxicology 26 (2005), pp. 229–240.
   PubMed Web of Science ®Google Scholar
• LoPachin, R. M., He, D., Reid, M. L., and Opanashuk, L. A., 2004. 2,5-Hexanedione-induced changes in the monomeric neurofilament protein content of rat spinal cord fractions, Toxicol. Appl. Pharmacol. 198 (2004), pp. 61–73.
   PubMed Web of Science ®Google Scholar
• LoPachin, R. M., Jortner, B. S., Reid, M. L., and Das, S., 2003. γ-Diketone central neuropathy: Quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots, Toxicol. Appl. Pharmacol. 193 (2003), pp. 29–46.
   PubMed Web of Science ®Google Scholar
• LoPachin, R. M., Ross, J. F., Reid, M. L., Das, S., Mansukhani, S., and Lehning, E. J., 2002. Neurological evaluation of toxic axonopathies in rats: Acrylamide and 2,5-hexanedione, NeuroToxicology 23 (2002), pp. 95–110.
   PubMed Web of Science ®Google Scholar
• Monaco, S., Wongmongkolrit, T., Shearson, C. M., Patton, A., Schaetzle, B., Autilio-Gambetti, L., Gambetti, P., and Sayre, L. M., 1990. Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport, Brain Res. 519 (1990), pp. 73–81.
   PubMed Web of Science ®Google Scholar
• Pyle, S. J., Amarnath, V., Graham, D. G., and Anthony, D. C., 1992. The role of pyrrole formation in the alteration of neurofilament transport induced during exposure to 2,5-hexanedione, J. Neuropathol. Exp. Neurol. 51 (1992), pp. 451–458.
   PubMed Web of Science ®Google Scholar
• Rosenberg, C. K., Genter, M. B., Szakal-Quin, G., Anthony, D. C., and Graham, D. G., 1986. dl- Versus meso-3,4-Dimethyl-2,5-hexanedione: A morphometric study of the proximo-distal distribution of axonal swellings in the anterior root of the rat, Toxicol. Appl. Pharmacol. 87 (1986), pp. 363–373.
   Web of Science ®Google Scholar
• Shea, T. B., Jung, C., Yabe, J., Ma, D., and Fischer, I., 1998. "Extensive phosphorylation and axonal transport of triton-soluble neurofilament subunits". In: Herrmann, H. D., and Harris, R. A., eds. Sub-cellular Biochemistry. Vol. 31. New York: Plenum Press; 1998. pp. 527–561, Intermediate Filaments.
   Google Scholar
• Spencer, P. S., Bischoff, M. C., and Schaumburg, H. H., 1978. On the specific molecular configuration of neurotoxic aliphatic hexacarbon compounds causing central-peripheral distal axonopathy, Toxicol. App. Pharmacol. 44 (1978), pp. 17–28.
   PubMed Web of Science ®Google Scholar
• Spencer, P. S., Schaumburg, H. H., Sabri, M. I., and Veronesi, B., 1980. The enlarging view of hexacarbon neurotoxicity, CRC Crit. Rev. Toxicol. 7 (1980), pp. 279–356.
   Web of Science ®Google Scholar
• Stone, J. D., Peterson, A. P., Eyer, J., Oblak, T. G., and Sickles, D. W., 1999. Axonal neurofilaments are nonessential elements of toxicant-induced reductions in fast axonal transport: Video-enhanced differential interference microscopy in peripheral nervous system axons, Toxicol. Appl. Pharmacol. 161 (1999), pp. 50–58.
   PubMed Web of Science ®Google Scholar
• Stone, J. D., Peterson, A. P., Eyer, J., Oblak, T. G., and Sickles, D. W., 2001. Neurofilaments are nonessential to the pathogenesis of toxicant-induced axonal degeneration, J. Neurosci. 21 (2001), pp. 2278–2287.
   PubMed Web of Science ®Google Scholar
• Stone, J. D., Peterson, A. P., Eyer, J., and Sickles, D. W., 2000. Neurofilaments are non-essential elements of toxicant-induced reductions in fast axonal transport: Pulse labeling in CNS neurons, NeuroToxicology 21 (2000), pp. 447–457.
   PubMed Web of Science ®Google Scholar
• Wang, Q. S., Hou, L. Y., Zhang, C. L., Song, F. Y., and Xie, K. Q., 2008. Changes of cytoskeletal proteins in nerve tissues and serum of rats treated with 2,5-hexanedione, Toxicology 244 (2008), pp. 166–178.
   PubMed Web of Science ®Google Scholar
• Xu, G. Z., Singh, M. P., Gopal, D., and Sayre, L. M., 2001. Novel 2,5-hexanedione analogues. Substituent-induced control of the protein cross-linking potential and oxidation susceptibility of the resulting primary amine-derived pyrroles, Chem. Res. Toxicol. 14 (2001), pp. 264–274.
   PubMed Web of Science ®Google Scholar
• Yu, R. C., Hattis, D., Landaw, E. M., and Froines, J. R., 2002. Toxicokinetic interaction of 2,5-hexanedione and methyl ethyl ketone, Arch. Toxicol. 75 (2002), pp. 643–652.
   PubMed Web of Science ®Google Scholar
• Zhu, M., Spink, D. C., Yan, B., Bank, S., and DeCaprio, A. P., 1994. Formation and structure of crosslinking and monomeric pyrrole autoxidation products in 2,5-hexanedione-treated amino acids, peptides, and protein, Chem. Res. Toxicol. 7 (1994), pp. 551–558.
   PubMed Web of Science ®Google Scholar
• Zhu, M., Spink, D. C., Yan, B., Bank, S., and DeCaprio, A. P., 1995. Inhibition of 2,5-hexanedione-induced covalent protein crosslinking by biological thiols: Chemical mechanisms and toxicological implications, Chem. Res. Toxicol. 8 (1995), pp. 764–771.
   PubMed Web of Science ®Google Scholar